Literature DB >> 2666905

Expression of the c-rel and c-myc proto-oncogenes in avian tissues.

B E Moore1, H R Bose.   

Abstract

Reticuloendotheliosis virus (REV-T) transforms very immature avian lymphoid cells and induces a rapidly fatal lymphoma. The viral oncogene, v-rel, encodes a 59 kDa phosphoprotein which is complexed with cellular proteins in the cytosol of REV-T transformed lymphoid cell lines. The proto-oncogene, c-rel, has been highly conserved among both vertebrate and invertebrate species. The expression of both the c-rel and c-myc protoncogenes was characterized during avian development. Two distinct rel-related transcripts were detected. A 4.0kb mRNA was the principal transcript expressed in cells of hematopoietic origin with highest levels detected in bursa, thymus, and spleen tissue obtained from hatched birds. Relatively low levels of this 4.0 kb transcript were detected in nonhematopoietic tissues. Thus, the distribution of this mRNA correlated with the presence of target cells for transformation by v-rel. The 4.0 kb c-rel transcript had a half-life of nearly 2 h in an avian lymphoid cell line. A second rel-related transcript was identified in the ovary of young hens and appeared to be expressed either in primary oocytes or in the developing follicle. This 2.6 kb c-rel mRNA was detected at substantially lower levels in cells of hematopoietic origin. Using radiolabeled RNA probes, the 2.6 kb c-rel transcript was not detected in liver, brain, testes, or muscle. The c-myc proto-oncogene was also expressed in cells of hematopoietic tissue and ova obtained from hatched birds. While intermediate RNA levels were observed in muscle and liver cells, the c-myc gene was not expressed in avian testes.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2666905

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  9 in total

1.  Role of the NF-κB transcription factor c-Rel in the generation of CD8+ T-cell responses to Toxoplasma gondii.

Authors:  Kimberly A Jordan; Christopher D Dupont; Elia D Tait; Hsiou-Chi Liou; Christopher A Hunter
Journal:  Int Immunol       Date:  2010-11       Impact factor: 4.823

2.  c-Rel arrests the proliferation of HeLa cells and affects critical regulators of the G1/S-phase transition.

Authors:  J Bash; W X Zong; C Gélinas
Journal:  Mol Cell Biol       Date:  1997-11       Impact factor: 4.272

3.  Identification of a rel-related protein in the nucleus during the S phase of the cell cycle.

Authors:  R B Evans; P D Gottlieb; H R Bose
Journal:  Mol Cell Biol       Date:  1993-10       Impact factor: 4.272

4.  Evolution of the oncogenic potential of v-rel: rel-induced expression of immunoregulatory receptors correlates with tumor development and in vitro transformation.

Authors:  J Nehyba; R Hrdlicková; E H Humphries
Journal:  J Virol       Date:  1994-04       Impact factor: 5.103

5.  Characterization of a novel promoter insertion in the c-rel locus.

Authors:  N Kabrun; N Bumstead; M J Hayman; P J Enrietto
Journal:  Mol Cell Biol       Date:  1990-09       Impact factor: 4.272

6.  The Rel subunit of NF-kappaB-like transcription factors is a positive and negative regulator of macrophage gene expression: distinct roles for Rel in different macrophage populations.

Authors:  G Grigoriadis; Y Zhan; R J Grumont; D Metcalf; E Handman; C Cheers; S Gerondakis
Journal:  EMBO J       Date:  1996-12-16       Impact factor: 11.598

7.  v-rel induces expression of three avian immunoregulatory surface receptors more efficiently than c-rel.

Authors:  R Hrdlicková; J Nehyba; E H Humphries
Journal:  J Virol       Date:  1994-01       Impact factor: 5.103

8.  v-rel Induces ectopic expression of an adhesion molecule, DM-GRASP, during B-lymphoma development.

Authors:  G Zhang; C Slaughter; E H Humphries
Journal:  Mol Cell Biol       Date:  1995-03       Impact factor: 4.272

9.  Contrasting expression patterns of three members of the myc family of protooncogenes in the developing and adult mouse kidney.

Authors:  G Mugrauer; P Ekblom
Journal:  J Cell Biol       Date:  1991-01       Impact factor: 10.539

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.